Anakinra, sold under the brand name Kineret, is a biopharmaceutical medication used to treat rheumatoid arthritis, cryopyrin-associated periodic syndromes, familial Mediterranean fever, and Still’s disease. It is a slightly modified recombinant version of the human interleukin 1 receptor antagonist protein.<\/p>\n
KINERET\u00ae (anakinra) injection, for subcutaneous use Initial U.S. Approval: 2001 <\/strong><\/p>\n Kineret (anakinra) for injection may be accessed in India through a named-patient import process<\/strong>\u00a0with a valid doctor\u2019s prescription, and\u00a0Indian Pharma Network (IPN), New Delhi, assists with compliant sourcing<\/strong>\u00a0and delivery of specialty medicines subject to regulatory approvals.<\/p>\n Indian Pharma Network (IPN), based in New Delhi, helps patients and healthcare providers with the sourcing and import coordination of specialty medicines in compliance with applicable Indian regulations.<\/strong>\u00a0Availability, import eligibility, pricing, and delivery timelines may vary and are subject to regulatory approvals and documentation requirements.<\/p>\n IPN having representation in<\/strong>\u00a0Delhi, Gurugram, Mumbai, Bengaluru, Kolkata, Chennai, Pune, Ahmedabad, Hyderabad, Chandigarh, Jaipur, and Lucknow.<\/p>\n Named-patient import facilitator contact details<\/strong> Patients are advised to independently verify the credentials, licensing, and regulatory compliance of any facilitator before proceeding.<\/em><\/p>\n NEWS\/UPDATES<\/p>\n Note:<\/strong><\/em> Kineret (anakinra) is indicated for treating moderately to severely active Rheumatoid Arthritis (RA) in adults failing other DMARDs, and for rare autoinflammatory conditions like Cryopyrin-Associated Periodic Syndromes (CAPS), including NOMID, and Deficiency of Interleukin-1 Receptor Antagonist (DIRA), plus Still’s Disease (SJIA\/AOSD) in specific age groups, working by blocking inflammation-causing interleukin-1. It’s an immunosuppressant that blocks immune chemical messengers.<\/p>\nIs Kineret (anakinra) available in India?<\/h4>\n
How to get Kineret for injection delivered in India?<\/h4>\n
Who can help source Kineret for injection in India legally?<\/h4>\n
\nCompany Name:<\/strong>\u00a0Indian Pharma Network (IPN)
\nAddress:<\/strong>\u00a060\/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016
\nFor sourcing and import coordination of specialty medicines, contact:<\/strong>
\nMr. Tarun:<\/strong>\u00a0+91 9891 296 838
\nMr. Neeraj:<\/strong>\u00a0+91 9811 747 774
\nEmail:\u00a0info@indianpharmanetwork.co.in<\/a><\/strong><\/p>\n\n
\nWe are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.\u00a0Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India<\/a>. With over two decades of industry experience, IPN offers extensive coverage across India.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"Kineret (anakinra) \u2013 Rheumatoid Arthritis (RA) Therapy in India<\/h2>\n
\n\n
\n Brand Name:<\/strong><\/td>\n Kineret<\/td>\n<\/tr>\n \n Generic Name:<\/strong><\/td>\n anakinra<\/td>\n<\/tr>\n \n Strength:<\/strong><\/td>\n Injection: 100 mg\/0.67 mL solution in a single-use prefilled syringe for
\nsubcutaneous injection. Graduated syringe allows for doses between 20 mg and 100 mg.<\/td>\n<\/tr>\n\n Manufacturer:<\/strong><\/td>\n Swedish Orphan Biovitrum AB (publ)<\/td>\n<\/tr>\n \n Approved By:<\/strong><\/td>\n EMA, USFDA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n